• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

8.410 -0.690 (-7.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 441,965
Open 8.960
Bid (Size) 8.200 (100)
Ask (Size) 9.440 (700)
Prev. Close 9.100
Today's Range 8.320 - 9.050
52wk Range 5.810 - 11.25
Shares Outstanding 10
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bioventus (BVS) Q4 2025 Earnings Call Transcript ↗
March 05, 2026
Bioventus (BVS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook ↗
March 05, 2026
Via Chartmill
Topics Earnings

Performance

YTD
+16.6%
+16.6%
1 Month
+3.8%
+3.8%
3 Month
+18.6%
+18.6%
6 Month
+17.0%
+17.0%
1 Year
-11.1%
-11.1%

More News

Read More
News headline image
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
February 24, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
May 06, 2025
Via Benzinga
News headline image
Examining the Future: Bioventus's Earnings Outlook ↗
May 05, 2025
Via Benzinga
News headline image
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
November 04, 2025
Via Chartmill
News headline image
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth ↗
November 04, 2025
Via Chartmill
Topics Earnings
News headline image
Bioventus Reports Third Quarter Financial Results
November 04, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
October 28, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 22, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
September 03, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
August 07, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Inc. (NASDAQ:BVS) Reports Mixed Q2 2025 Earnings Amid Muted Market Reaction ↗
August 06, 2025
Via Chartmill
News headline image
Bioventus Reports Second Quarter Financial Results
August 06, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
August 04, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
July 30, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
July 29, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports First Quarter Financial Results
May 06, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
April 28, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
April 07, 2025
Via Benzinga

Frequently Asked Questions

Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 8.410
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Bioventus Inc. - Class A Common Stock?
The market capitalization of Bioventus Inc. - Class A Common Stock is 84.10
How many shares of Bioventus Inc. - Class A Common Stock are outstanding?
Bioventus Inc. - Class A Common Stock has 84 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap